Modeling the adaptive immune system: Predictions and simulations

Bioinformatics

Volumn 23, Issue 24, 2007, Pages 3265-3275

  Lundegaard, Claus ^a   Lund, Ole ^a   Keşmir, Can ^a,b   Brunak, Søren ^a   Nielsen, Morten ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME;

ACCURACY; ADAPTIVE IMMUNITY; ALGORITHM; ANTIGEN BINDING; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BIOINFORMATICS; CELLULAR IMMUNITY; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; MATHEMATICAL MODEL; NONHUMAN; PERFORMANCE MEASUREMENT SYSTEM; PREDICTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIMULATION; T LYMPHOCYTE; VALIDATION PROCESS;

EID: 36949034073     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btm471     Document Type: Review

References (167)

1. Abele,R. and Tampé,R. (2004) The ABCs of immunology: Structure and function of TAP, the transporter associated with antigen processing. Physiology, 19, 216-224.
2. Adams,H.P. and Koziol,J.A. (1995) Prediction of binding to MHC class I molecules. J. Immunol. Methods, 185, 181-190.
3. Alix,A.J. (1999) Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine, 18, 311-314.
4. Altschul,S.F. et al. (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402.
5. Andersen,M.H. et al. (2006) Cytotoxic T cells. J. invest. dermatol., 126, 32-41.
6. Assarsson,E. et al. (2007) A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol., 178, 7890-7901.
7. Baldi,P. and Brunak,S. (2001) Bioinformatics: The Machine Learning Approach, 2nd edition. MIT Press, Cambridge, Mass.
8. Batori,V. et al. (2006) An in silico method using an epitope motif database for predicting the location of antigenic determinants on proteins in a structural context. J. Mol. Recognit., 19, 21-29.
9. Bendtsen,J.D. et al. (2004) Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol., 340, 783-795.
10. Bhasin,M. and Raghava,G.P. (2004) Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci., 13, 596-607.
11. Bhasin,M. and Raghava,G.P. (2007) A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J. Biosci., 32, 31-42.
12. Bhasin,M. and Raghava,G.P.S. (2005) Pcleavage: An SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Res., 33, W202-W207.
13. Blythe,M.J. and Flower,D.R. (2005) Benchmarking B cell epitope prediction: Underperformance of existing methods. Protein Sci., 14, 246-248.
14. Blythe,M.J. et al. (2002) JenPep: A database of quantitative functional peptide data for immunology. Bioinformatics, 18, 434-439.
15. Boer,R.J.d. and Noest,A.J. (1998) T cell renewal rates, telomerase, and telomere length shortening. J. Immunol., 160, 5832-5837.
16. Boer,R.J.d. et al. (2003a) Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection. J. Immunol., 171, 3928-3935.
17. Boer,R.J.d. et al. (2003b) Estimating average cellular turnover from 5-bromo-2′- deoxyuridine (BrdU) measurements. Proceedings, 270, 849-858.
18. Borghans,J.A.M. and de Boer,R.J. (2007) Quantification of T-cell dynamics: From telomeres to DNA labeling. Immunol. Rev., 216 35-47.
19. Brusic,V. et al. (1994) Prediction of MHC binding peptides using artificial neural networks. In Stonier,R.J. and Yu,X.S. (ed.) Complex Systems: Mechanism of Adaptation. Amsterdam, IOS Press, pp. 253-260.
20. Brusic,V. et al. (1998) Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics, 14, 121-130.
21. Brusic,V. et al. (2002) Prediction of promiscuous peptides that bind HLA class I molecules. Immunol. Cell. Biol., 80, 280-285.
22. Bui,H.H. et al. (2005) Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics, 57, 304-314.
23. Burton,D.R. (2002) Antibodies, viruses and vaccines. Nat. Rev. Immunol., 2, 706-713.
24. Buus,S. et al. (2003) Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens, 62, 378-384.
25. Carneiro,J. et al. (2007) When three is not a crowd: A crossregulation model of the dynamics and repertoire selection of regulatory CD4+ T cells. Immunol. Rev., 216, 48-68.
26. Castellino,F. et al. (1997) Antigen presentation by MHC class II molecules: Invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum. Immunol., 54, 159-169.
27. Castiglione,F. and Piccoli,B. (2007) Cancer immunotherapy, mathematical modeling and optimal control. J.Theor. Biol., 247, 723-732.
28. Chang,S.T. et al. (2006) Peptide length-based prediction of peptide-MHC class II binding. Bioinformatics, 22, 2761-2767.
29. Consogno,G. et al. (2003) Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3. Blood, 101, 1038-1044.
30. Cortes,C. and Vapnik,V. (1995) Support-vector networks. Mach. Learn. 20, 273-297.
31. Dahlback,M. et al. (2006) Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration. PLoS pathog., 2, e124.
32. Daniel,S. et al. (1998) Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J. Immunol., 161, 617-624.
33. Davenport,M.P. et al. (2007) Understanding the mechanisms and limitations of immune control of HIV. Immunol. Rev., 216, 164-175.
34. Davies,M.N. and Flower,D.R. (2007) Harnessing bioinformatics to discover new vaccines. Drug Discov. Today, 12, 389-395.
35. Daza-Vamenta,R. et al. (2004) Genetic divergence of the rhesus Macaque major histocompatibility complex. Genome Res., 14, 1501-1515.
36. de Groot,A.S. (2006) Immunomics: Discovering new targets for vaccines and therapeutics. Drug Discov. Today, 11, 203-209.
37. de Groot,A.S. and Moise,L. (2007) Prediction of immunogenicity for therapeutic proteins: State of the art. Curr. Opin. Drug Discov. Devel., 10, 332-340.
38. Debelle,L. et al. (1992) Predictions of the secondary structure and antigenicity of human and bovine tropoelastins. Eur. Biophys. J. 21, 321-329.
39. Deenick,E.K. et al. (2003) Stochastic model of T cell proliferation: A calculus revealing IL-2 regulation of precursor frequencies, cell cycle time, and survival. J. Immunol., 170 4963-4972.
40. Donnes,P. and Kohlbacher,O. (2005) Integrated modeling of the major events in the MHC class I antigen processing pathway. Protein Sci. 14, 2132-2140.
41. Douek,D.C. et al. (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature, 396, 690-695.
42. Doytchinova,I. et al. (2004) Transporter associated with antigen processing preselection of peptides binding to the MHC: A bioinformatic evaluation. J. Immunol., 173, 6813-6819.
43. Doytchinova,I.A. and Flower,D.R. (2002) Physicochemical explanation of peptide binding to HLA-A *0201 major histocompatibility complex: A three-dimensional quantitative structure-activity relationship study. Proteins, 48, 505-518.
44. Doytchinova,I.A. et al. (2006) EpiJen: A server for multistep T cell epitope prediction. BMC Bioinformatics, 7, 131.
45. Dutilh,B.E. and de Boer,R.J. (2003) Decline in excision circles requires homeostatic renewal or homeostatic death of naive T cells. J. Theor. Biol., 224, 351-358.
46. Enshell-Seijffers,D. et al. (2003) The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J. Mol. Biol., 334, 87-101.
47. Falk,K. et al. (1990) Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature, 348 248-251.
48. Fleury,D. et al. (2000) Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins, 40, 572-578.
49. Fruci,D. et al. (2001) Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum. Immunity, 15, 467-476.
50. Gett,A.V. and Hodgkin,P.D. (2000) A cellular calculus for signal integration by T cells. Nature immunol., 1, 239-244.
51. Godkin,A.J. et al. (2001) Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J. Immunol., 166, 6720-6727.
52. Greenbaum,J.A. et al. (2007) Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J. Mol. Recognit., 20, 75-82.
53. Gulukota,K. et al. (1997) Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J. Mol. Biol., 267, 1258-1267.
54. Hakenberg,J. et al. (2003) MAPPP: MHC class I antigenic peptide processing prediction. Appl. Bioinformatics, 2, 155-158.
55. Halperin,I. et al. (2003) Sitelight: Binding-site prediction using phage display libraries. Protein Sci., 12, 1344-1359.
56. Haste,A.P. et al. (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci., 15 2558-2567.
57. Hazenberg,M.D. et al. (2000) Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat. med. 6, 1036-1042.
58. Hazenberg,M.D. et al. (2003) Thymic output: A bad TREC record. Nature immunol., 4, 97-99.
59. Hellerstein,M.K. (1999) Measurement of T-cell kinetics: Recent methodologic advances. Immunol. Today, 20, 438-441.
60. Hertz,T. and Yanover,C. (2007) Identifying HLA supertypes by learning distance functions. Bioinformatics, 23, e148-155.
61. Holzhutter,H.G. and Kloetzel,P.M. (2000) A kinetic model of vertebrate 20{S} proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates. Biophys. J., 79 1196-1205.
62. Holzhutter,H.G. et al. (1999) A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. J. Mol. Biol., 286, 1251-1265.
63. Hopp,T.P. (1994) Different views of protein antigenicity. Pept. Res. 7, 229-231.
64. Hopp,T.P. and Woods,K.R. (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78, 3824-3828.
65. Hopp,T.P. and Woods,K.R. (1983) A computer program for predicting protein antigenic determinants. Mol. immunol., 20, 483-489.
66. Huang,J. et al. (2006) MIMOX: A web tool for phage display based epitope mapping. BMC Bioinformatics, 7, 451.
67. Hughey,R. and Krogh,A. (1996) Hidden Markov models for sequence analysis: Extension and analysis of the basic method. Comput. Appl. Biosci., 12, 95-107.
68. Jameson,B.A. and Wolf,H. (1988) The antigenic index: A novel algorithm for predicting antigenic determinants. Comput. Appl. Biosci., 4 181-186.
69. Janeway,C.A. et al. (2001) Immunobiology: The Immune System in Health and Disease. Garland Publications, New York, London.
70. Jesaitis,A.J. et al. (1999) Actin surface structure revealed by antibody imprints: Evaluation of phage-display analysis of anti-actin antibodies. Protein Sci., 8, 760-770.
71. Jojic,N. et al. (2006) Learning MHC I-peptide binding. Bioinformatics, 22, e227-235.
72. Kall,L. et al. (2004) A combined transmembrane topology and signal peptide prediction method. J. Mol. Biol., 338, 1027-1036.
73. Karpenko,O. et al. (2005) Prediction of MHC class II binders using the ant colony search strategy. Artif. Intell. Med., 35, 147-156.
74. Kawashima,S. and Kanehisa,M. (2000) AAindex: Amino acid index database. Nucleic Acids Res., 28, 374.
75. Kesmir,C. et al. (2002) Prediction of proteasome cleavage motifs by neural networks. Protein Eng., 15, 287-296.
76. Kohler,B. et al. (2000) A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system. I. viral characteristics and polarized responses. Vaccine, 19, 862-876.
77. Kondo,A. et al. (1997) Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes. Immunogenetics, 45, 249-258.
78. Korber,B. et al. (2006) Immunoinformatics comes of age. PLoS Comput. Biol., 2, e71.
79. Kubo,R.T. et al. (1994) Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol., 152, 3913-3924.
80. Kulkarni-Kale,U. et al. (2005) CEP: A conformational epitope prediction server. Nucleic Acids Res., 33, W168-171.
81. Kuttler,C. et al. (2000) An algorithm for the prediction of proteasomal cleavages. J. Mol. Biol., 298, 417-429.
82. Larsen,J.E. et al. (2006) Improved method for predicting linear B-cell epitopes. Immunome Res., 2, 2.
83. Larsen,M.V. et al. (2005) An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur. J. Immunol., 35, 2295-2303.
84. Larsen,M.V. et al. (2006) TAP-independent MHC class I presentation. Curr. Immunol. Rev., 2, 233-245.
85. Lawrence,C.E. et al. (1993) Detecting sutble sequence signals: A Gibbs sampling strategy for multiple alignment. Science, 262 208-214.
86. Lefranc,M.P. (2005) IMGT, the international ImMunoGeneTics information system(R): A standardized approach for immunogenetics and immunoinformatics. Immunome Res., 1, 3.
87. Levitt,M. (1976) A simplified representation of protein conformations for rapid simulation of protein folding. J. Mol. Biol., 104, 59-107.
88. Li,Z. et al. (2004) The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev., 18, 1-11.
89. Logean,A. et al. (2001) Customized versus universal scoring functions: Application to class I MHC-peptide binding free energy predictions. Bioorg. Med. Chem. Lett., 11, 675-679.
90. Lollini,P.L. et al. (2006) Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator. BMC Bioinformatics, 7, 352.
91. Loureiroa,J. and Ploegha,H.L. (2006) Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv. Immunol., 92, 225-305.
92. Louzoun,Y. et al. (2006) T-cell epitope repertoire as predicted from human and viral genomes. Mol. Immunol., 43, 559-569.
93. Lund,O. et al. (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics, 55 797-810.
94. Lund,O. et al. (2005) Immunological Bioinformatics. MIT Press, Cambridge, MA.
95. Lundegaard,C. et al. (2004) MHC class I epitope binding prediction trained on small data sets. In Artificial Immune Systems, Proceedings Springer, pp. 217-225.
96. Maksyutov,A.Z. and Zagrebelnaya,E.S. (1993) ADEPT: A computer program for prediction of protein antigenic determinants. Comput. Appl. Biosci., 9, 291-297.
97. Mamitsuka,H. (1998) Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models. Proteins, 33, 460-474.
98. Meister,G.E. et al. (1995) Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine, 13, 581-591.
99. Meloen,R.H. et al. (2000) Mimotopes: Realization of an unlikely concept. J. Mol. Recognit., 13, 352-359.
100. Mirza,O. et al. (2000) Dominant epitopes and allergic cross-reactivity: Complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1. J. Immunol., 165, 331-338.
101. Mohri,H. et al. (1998) Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science, 279, 1223-1227.
102. Mohri,H. et al. (2001) Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med., 194, 1277-1287.
103. Moreau,V. et al. (2006) Discontinuous epitope prediction based on mimotope analysis. Bioinformatics, 22, 1088-1095.
104. Motta,S. et al. (2005) Modelling vaccination schedules for a cancer immunoprevention vaccine. Immunome Res., 1, 5.
105. Moutaftsi,M. et al. (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol., 24, 817-819.
106. Mumey,B.M. et al. (2003) A new method for mapping discontinuous antibody epitopes to reveal structural features of proteins. J. Comput. Biol., 10, 555-567.
107. Murugan,N. and Dai,Y. (2005) Prediction of MHC class II binding peptides based on an iterative learning model. Immunome Res., 1, 6.
108. Nielsen,M. et al. (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci., 12, 1007-1017.
109. Nielsen,M. et al. (2004) Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics, 20, 1388-1397.
110. Nielsen,M. et al. (2005) The role of the proteasome in generating cytotoxic T-cell epitopes: Insights obtained from improved predictions of proteasomal cleavage. Immunogenetics, 57, 33-41.
111. Nielsen,M. et al. (2007a) Quantitative, pan-specific predictions of peptide binding to HLA- A and-B locus molecules. PLoS ONE, 2 e796.
112. Nielsen,M. et al. (2007b) Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics, 8, 238.
113. Noguchi,H. et al. (2002) Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. J. Biosci. Bioeng., 94, 264-270.
114. Novotny,J. et al. (1986) Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proc. Natl. Acad. Sci. USA, 83, 226-230.
115. Nussbaum,A.K. et al. (2001) {PAProC}: A prediction algorithm for proteasomal cleavages available on the {WWW}. Immunogenetics, 53, 87-94.
116. Odorico,M. and Pellequer,J.L. (2003) BEPITOPE: Predicting the location of continuous epitopes and patterns in proteins. J. Mol. Recognit. 16, 20-22.
117. Pamer,E.G. et al. (1991) Expression and deletion analysis of the Trypanosoma brucei rhodesiense cysteine protease in Escherichia coli. Infect. Immun., 59, 1074-1078.
118. Pappalardo,F. et al. (2006) Analysis of vaccine's schedules using models. Cell. Immunol., 244, 137-140.
119. Parker,J.M. et al. (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry, 25, 5425-5432.
120. Parker,K.C. et al. (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol., 152, 163-175.
121. Pellequer,J.L. et al. (1991) Predicting location of continuous epitopes in proteins from their primary structures. Meth. Enzymol. 203, 176-201.
122. Pellequer,J.L. et al. (1993) Correlation between the location of antigenic sites and the prediction of turns in proteins. Immunol. Lett., 36, 83-99.
123. Peters,B. and Sette,A. (2005) Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics, 6, 132.
124. Peters,B. et al. (2003) Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J. Immunol., 171, 1741-1749.
125. Peters,B. et al. (2005) The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol., 3, e91.
126. Peters,B. et al. (2006) A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput. Biol. 2, c65.
127. Petrovsky,N. and Brusic,V. (2006) Bioinformatics for study of autoimmunity. Autoimmunity, 39, 635-643.
128. Rammensee,H. et al. (1999) SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics, 50, 213-219.
129. Rapin,N. et al. (2006) Modelling the human immune system by combining bioinformatics and systems biology approaches. J. Biol. Phys., 32, 335-353.
130. Reche,P.A. and Reinherz,E.L. (2004) Definition of MHC supertypes through clustering of MHC peptide binding repertoires. In Artificial Immune Systems, Proceedings. pp. 189-196.
131. Reche,P.A. et al. (2002) Prediction of MHC class I binding peptides using profile motifs. Hum. Immunol., 63, 701-709.
132. Regenmortel,M.H.V.V. and Muller,S. (1999) Synthetic Peptides as Antigens. Elsevier, Amsterdam.
133. Revy,P. et al. (2001) Functional antigen-independent synapses formed between T cells and dendritic cells. Nat. Immunol., 2 925-931.
134. Ribeiro,R.M. et al. (2002) Modeling deuterated glucose labeling of T-lymphocytes. Bull. Math. Biol., 64, 385-405.
135. Rothbard,J.B. and Taylor,W.R. (1988) A sequence pattern common to T cell epitopes. Embo. J., 7, 93-100.
136. Rotzschke,O. et al. (1991) Exact prediction of a natural T cell epitope. Eur. J. Immunol., 21, 2891-2894.
137. Saxová,P. et al. (2003) Predicting proteasomal cleavage sites: a comparison of available methods. Int. Immunol., 15, 781-787.
138. Schafer,J.R. et al. (1998) Prediction of well-conservcd {HIV}-1 ligands using a matrix-based algorithm, EpiMatrix. Vaccine, 16 1880-1884.
139. Schirle,M. et al. (2001) Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J. Immunol. Meth., 257 1-16.
140. Schreiber,A. et al. (2005) 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins. J. Comput. Chem., 26, 879-887.
141. Seiden,P.E. and Celada,F. (1992) A model for simulating cognate recognition and response in the immune system. J. Theor. Biol., 158, 329-357.
142. Sette,A. and Sidney,J. (1998) HLA supertypes and supermotifs: A functional perspective on HLA polymorphism. Curr. Opin. Immunol., 10, 478-482.
143. Sette,A. and Sidney,J. (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA- A and-B polymorphism. Immunogenetics, 50, 201-212.
144. Sette,A. et al. (1989) Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. Natl. Acad. Sci. USA, 86, 3296-3300.
145. Smith,G.P. and Petrenko,V.A. (1997) Phage display. Chem. Rev., 97, 391-410.
146. Sollner,J. (2006) Selection and combination of machine learning classifiers for prediction of linear B-cell epitopes on proteins. J. Mol. Recognit., 19, 209-214.
147. Sollner,J. and Mayer,B. (2006) Machine learning approaches for prediction of linear B-cell epitopes on proteins. J. Mol. Recognit. 19, 200-208.
148. Stoltze,L. et al. (2000) Two new proteases in the MHC class I processing pathway. Nat. Immunol., 1, 413-418.
149. Stryhn,A. et al. (1996) Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: Quantitation by peptide libraries and improved prediction of binding. Eur. J. Immunol., 26, 1911-1918.
150. Swets,J.A. (1988) Measuring the accuracy of diagnostic systems. Science, 240, 1285-1293.
151. Sylvester-Hvid,C. et al. (2004) SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens, 63, 395-400.
152. Tarnovitski,N. et al. (2006) Mapping a neutralizing epitope on the SARS coronavirus spike protein: Computational prediction based on affinity-selected peptides. J. Mol. Biol., 359, 190-201.
153. Tenzer,S. et al. (2005) Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell. Mol. Life Sci., 62, 1025-1037.
154. Tenzer,S. et al. (2004) Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility. J. Immunol., 172, 1083-1091.
155. Thompson,C.B. (1995) New insights into {V}({D}){J} recombination and its role in the evolution of the immune system. Immunity, 3, 531-539.
156. Thornton,J.M. et al. (1986) Location of 'continuous' antigenic determinants in the protruding regions of proteins. Embo. J., 5 409-413.
157. Tong,J.C. et al. (2007) Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform., 8, 96-108.
158. van Regenmortel,M.H. and Pellequer,J.L. (1994) Predicting antigenic determinants in proteins: Looking for unidimensional solutions to a three-dimensional problem? Pept. Res., 7, 224-228.
159. van Regenmortel,M.H.V. (1996) Mapping epitope structure and activity: from one-dimensional prediction to four-dimensional description of antigenic specificity. Methods, 9, 465-472.
160. Wang,M. et al. (2007) CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 25, 2823-2831.
161. Yewdell,J.W. and Bennink,J.R. (1999) Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol., 17, 51-88.
162. Yu,K. et al. (2002) Methods for prediction of peptide binding to MHC molecules: A comparative study. Mol. Med., 8, 137-148.
163. Zhang,G.L. et al. (2006) PRED(TAP): A system for prediction of peptide binding to the human transporter associated with antigen processing. Immunome Res., 2,3.
164. Zhang,Y. and Williams,D.B. (2006) Assembly of MHC class I molecules within the endoplasmic reticulum. Immunol. Res., 35, 151-162.
165. Zhang,Z. and Henzel,W.J. (2004) Signal peptide prediction based on analysis of experimentally verified cleavage sites. Protein Sci., 13, 2819-2824.
166. Zhihua,L. et al. (2004) Toward the quantitative prediction of T-cell epitopes: QSAR studies on peptides having affinity with the class I MHC molecular HLA-A *0201. J. Comput. Biol., 11, 683-694.
167. Zhu,S. et al. (2006) Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules. Bioinformatics 22, 1648-1655.